Apparatus for the percutaneous marking of a lesion

Information

  • Patent Grant
  • 10463446
  • Patent Number
    10,463,446
  • Date Filed
    Friday, September 23, 2005
    18 years ago
  • Date Issued
    Tuesday, November 5, 2019
    4 years ago
Abstract
A biopsy marking apparatus for placing a radiopaque marker at the location of a percutaneous biopsy. The biopsy marking apparatus comprises an introducer in combination with a radiopaque marker. The introducer ejects the radiopaque marker at the location of the biopsy. The introducer is configured to completely eject the radiopaque marker and prevent it from being subsequently drawn into the introducer as the introducer is removed from the biopsied tissue mass. The radiopaque marker has enhanced radiopaque characteristics and enhanced non-migration characteristics.
Description
FIELD OF THE INVENTION

This invention relates generally to an apparatus for the percutaneous positioning of a radiopaque marker for identifying the location of a lesion in a stereotactic biopsy procedure. More particularly, the invention relates to an introducer having a hollow cannula in combination with a movable stylet and a radiopaque marker disposed within the cannula and ejected from it by movement of the stylet.


DESCRIPTION OF THE RELATED ART

Tissue biopsies are commonly performed on many areas and organs of the body where it is desirable to ascertain whether or not the biopsied tissue is cancerous. Often, a lesion or other tissue to be biopsied is identified through use of an imaging technique such as a computerized axial tomography (CAT) scan, ultrasonography, and mammography.


One problem commonly encountered, especially in breast biopsies, is that the lesion is so small that the biopsy reduces its size to the extent that it is no longer visible by the imaging method employed. In such circumstances, it is desirable to place a radiopaque marker at the site of the biopsy to enable the medical practitioner subsequently to locate the lesion quickly and accurately in the event complete removal of the affected tissue is indicated. This problem is currently met by placing a radiopaque marker at the biopsy area by means of a cannula or similar device housing the marker.


More particularly, one of the markers heretofore in use is a staple-type clip. The clip is introduced through a large-diameter cannula, specifically one of 11 gauge.


Some practitioners employ an embolization coil as a marker. This requires them to find a cannula or hollow needle of a size to receive the coil and some means to force the coil through the needle, all the while trying to keep these components together and sterile.


Prior devices for marking a biopsy area have several other disadvantages. A significant disadvantage is that the marker is not always completely ejected from the cannula or can be drawn back into or toward the cannula by the vacuum created upon the withdrawal of the cannula, which results in the marker being moved from the intended site, leading to inaccurate identification of the location of the biopsy area. A second major disadvantage is that current markers have a tendency to migrate within the tissue, also causing error in determining the biopsy location.


SUMMARY OF THE INVENTION

The present invention provides a biopsy marking apparatus for the percutaneous placement of a marker at a biopsy site in a tissue mass to facilitate subsequent determination of the location of the biopsy site. The biopsy marking apparatus comprises an introducer having a handle to be grasped by a user, a cannula, a stylet, and a radiopaque marker. The cannula has a proximal end mounted to the handle and a distal end defining an insertion tip. The stylet is slidably received within the cannula for movement between a ready position in which a distal end of the stylet is spaced inwardly from the cannula tip to form a marker recess between the distal end of the stylet and the cannula tip, and an extended position in which the distal end of the stylet extends at least to the cannula tip to effectively fill the marker recess.


A plunger is movably mounted to the handle and operably engages the stylet, the plunger being movable between a first position and a second position for moving the stylet between the ready position and the extended position.


A latch is provided for fixing the stylet in the extended position to prevent retraction of the stylet from that position.


A radiopaque marker is disposed within the marker recess, whereby, when the plunger is moved between the first and second positions, the stylet is moved from the ready to the extended position to eject the radiopaque marker from the marker recess, and the latch fixes the stylet in the extended position to prevent the return of the marker to the marker recess.


The latch preferably comprises a detent on either the plunger or the handle and a catch on the other, the catch being receivable within the detent as the plunger is moved from the first to the second position.


In another aspect, the invention also provides a radiopaque marker having a marker body and an anchor extending away from the body for fixing the location of the radiopaque marker in a tissue mass by the tissue mass prolapsing about the anchor. Preferably, the body has an interior hollow portion forming an air trap to enhance the ultrasound characteristic of the radiopaque marker.


Other features and advantages of the invention will be apparent from the ensuing description in conjunction with the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS

In the drawings:



FIG. 1 is a plan view of an introducer used to place a radiopaque marker at a biopsy location in accordance with the invention;



FIG. 2 is an enlarged sectional view of the area II of FIG. 1, illustrating the position of a radiopaque marker within the introducer prior to ejection;



FIG. 3 is an enlarged sectional view of the area III of FIG. 1, illustrating the arrangement of a handle, a plunger, and a stylet of the introducer;



FIG. 4 is a sectional view taken along line 4-4 of FIG. 1 and illustrating the introducer in a ready condition;



FIG. 5 is a sectional view taken along line 4-4 of FIG. 1 and illustrating the introducer in a discharged condition;



FIG. 6 is an enlarged view of a first embodiment of a radiopaque marker according to the invention;



FIG. 7 is an enlarged view of a second embodiment of a radiopaque marker according to the invention;



FIG. 8 is an enlarged view of a third embodiment of a radiopaque marker according to the invention;



FIG. 9 is an enlarged view of a fourth embodiment of a radiopaque marker according to the invention;



FIG. 10 is a partially broken away perspective view, greatly enlarged, of a fifth embodiment of a radiopaque marker according to the invention;



FIG. 11 is a plan view of the radiopaque marker of FIG. 10;



FIG. 12 is a greatly enlarged view of a sixth embodiment of a radiopaque marker according to the invention;



FIG. 13 is a greatly enlarged view of a seventh embodiment of a radiopaque marker according to the invention;



FIG. 14 is a greatly enlarged view of an eighth embodiment of a radiopaque marker according to the invention; and



FIG. 15 is a greatly enlarged view of a ninth embodiment of a radiopaque marker according to the invention.





DETAILED DESCRIPTION


FIGS. 1 to 4 illustrate a biopsy marking apparatus 10 according to the invention, which is capable of the percutaneous placement of a radiopaque marker at the location of a tissue biopsy. The biopsy marking apparatus 10 comprises an introducer 12 and a radiopaque marker 14 (FIG. 2) contained within the introducer 12. The introducer 12 includes a handle 16 having a hollow interior 18. The handle 16 comprises a grip portion 20 from which extends a tapered nose portion 22. The grip portion 20 defines a rear opening 24 that provides access to the hollow interior 18. A pair of detents 26 are formed in the grip portion 20 near the rear opening 24. Channels 28 are formed on the interior surface of the grip portion 20 and extend from the rear opening 24 to the detents 26.


The nose portion 22 comprises a guide passage 30 extending from the tip of the nose portion 22 to the hollow interior 18 of the handle 16. The guide passage 30 decreases in diameter inwardly from the tip of the nose portion to form a cannula seat 32. Alternatively, the diameter of the guide passage 30 may be substantially equal to or slightly smaller than the outer diameter of a cannula 34, which in any case is press-fit within the cannula seat 32. As is customary, the cannula is formed with a hollow interior 36 and a sharpened tip 38.


A stylet 40 comprising a shaft 42 and a base 44 is received within the hollow interior 18 of the handle 16 in a manner such that the shaft 42 extends through the guide passage 30 and into the cannula interior 36 and the stylet base lies within the hollow interior 18.


A plunger 50 comprises a cylindrical body 52 from which extend a pair of catches 54 at diametrically opposed positions. The cylindrical body 52 is sized so that it is slidably received within the rear opening 24 of the handle 16 where it is so oriented with respect to the handle that the catches 54 are aligned with the guide channels 28.


It will be recognized that the foregoing construction provides a biopsy marking apparatus which may be preassembled as a unit and prepackaged, all under sterile conditions, thereby affording the practitioner substantially greater convenience and reliability. Such a construction also permits use of a narrower cannula, which may be of 14 gauge or smaller.


In operation, the introducer 12 begins in the ready condition shown in FIG. 4. In this condition, the stylet shaft is received within the cannula but does not extend to the cannula tip 38, thereby forming a marker recess 46 within the cannula 34, the radiopaque marker 14 is disposed within the marker recess 46, and the plunger 50 is in a position relative to the handle 20 in which the catches are outside the handle; that is, they are not received within the detents 26. However, the plunger 50 is so oriented with respect to the handle that the catches 54 are aligned with the guide channels 28.


With the introducer in the ready condition, the cannula is positioned so that its tip is at or near the location of a tissue mass where a biopsy has been taken. Preferably, the cannula tip is positioned by using imaging systems. The cannula tip 38 can be designed for enhanced visibility using common imaging systems, such as CAT scan, ultrasonography and mammography. Suitable cannula tips are disclosed in U.S. Pat. No. 5,490,521, issued Feb. 13, 1996 to R. E. Davis and G. L. McLellan, which is incorporated by reference. Ultrasound enhancement technology is also disclosed in U.S. Pat. No. 4,401,124, issued Aug. 30, 1983 to J. F. Guess, D. R. Dietz, and C. F. Hottinger; and U.S. Pat. No. 4,582,061, issued Apr. 15, 1986 to F. J. Fry.


Once the cannula is positioned at the desired location, the plunger 50 is moved from its first or ready condition as illustrated in FIGS. 1 to 4 to a second or discharged condition in which the catches 54 are received within the detents 26 to lock the plunger 50 in the discharged condition and the stylet shaft extends beyond the cannula tip 38. The catches 50 and detents combine to function as a latch for locking the plunger in the discharged condition. As the plunger 50 is moved from the ready condition to the discharged condition, the plunger 50 drives the stylet base 44 forward to advance the stylet shaft 42 within the cannula interior 36. As the stylet shaft 42 is advanced, the radiopaque marker 14 is ejected from the marker recess 46 through the cannula tip 38 and into the tissue at the biopsy location.


It is preferred that the stylet shaft 42 be sized in a manner such that when the plunger 50 is in the discharged condition the stylet shaft 42 extends beyond the cannula tip 38 to ensure the complete ejection of the radiopaque marker 14 from the marker recess 46. The extension of the stylet shaft 42 beyond the cannula tip 38 also prevents the radiopaque marker 14 from being drawn back into the marker recess upon the removal of the introducer 12 from the tissue mass, which can occur as the tissue mass collapses and is drawn towards and into the cannula by the resilient nature of the tissue mass and the creation of a vacuum by the cannula as it is withdrawn from the tissue.


The rate at which the plunger 50 is moved from the ready condition to the discharged condition is preferably manually controlled by the user to control the rate at which the marker 14 is ejected into the tissue mass. Manual control of the ejection rate of the radiopaque marker provides the user with the ability to adjust the position of the cannula tip as the marker is being ejected and thereby permits additional control of the final location of the marker within the tissue mass. In other words, “on-the-fly” adjustment of the cannula tip during positioning of the marker 14 enables a more accurate placement of the marker.


The biopsy marking apparatus 12 may be placed in a safety condition (not shown) before packaging or use by rotationally orienting the plunger 50 with respect to the handle 16 so that the catches 54 are out of alignment with the guide channels 28, whereby the plunger cannot be depressed or advanced within the handle. It will be apparent that the marking apparatus can be placed in the ready condition previously described simply by rotating the plunger relative to the handle until the catches 54 are aligned with the guide channels 28.


It will also be apparent that the biopsy marking apparatus 10 may incorporate or be fitted with any one of several known trigger devices, some of them spring-loaded, for advancement of the plunger 50. Such a trigger device is disclosed, for example, in U.S. Pat. No. 5,125,413, issued Jun. 30, 1992 to G. W. Baran.


It should be noted that as a variation of the foregoing procedure the cannula employed during the biopsy procedure might be left in place with its tip remaining at the site of the lesion. The introducer 12 of the present invention would then be directed to the site through the biopsy cannula or, alternatively, the marker 14 of the present invention would be introduced to the biopsy cannula and ejected from its tip into the tissue mass by fitting the biopsy cannula to the introducer 12 in place of the cannula 34.


The radiopaque marker 14 used in combination with the introducer 12 to mark the location of the tissue biopsy should not only be readily visible using contemporary imaging techniques but it should not migrate within the tissue from the position in which it is initially placed. FIGS. 6 to 15 disclose various embodiments of radiopaque markers 14 that are highly visible using contemporary imaging techniques and are resistant to migration in the tissue.



FIG. 6 illustrates a first embodiment 60 of a radiopaque marker comprising a coil spring 62 from which extend radiopaque fibers 64. The coil spring 62 is preferably made from platinum or any other material not rejected by the body. The coil spring 62 is wound to effectively form a hollow interior comprising one or more air pockets, which are highly visible using contemporary ultrasound imaging techniques. The radiopaque fibers 64 are preferably made from Dacron, which is also highly visible using current imaging techniques.


The radiopaque marker 60 is highly visible using any of the commonly employed contemporary imagining techniques because of the combination of reflective surfaces formed by the coils, the hollow interior and the air pockets of the coil spring 62, as well as the radiopaque fibers 64.


The coil spring 62 is pre-shaped prior to being loaded into the marker recess 46 so that it tends to form a circular shape as shown in FIG. 6 after it is ejected from the marker recess 46. The circular shape tends to resist migration within the tissue.



FIG. 7 illustrates a second embodiment 70 of a radiopaque marker having a star-burst configuration comprising a core 72 with multiple fingers 74 extending from the core.



FIG. 8 illustrates a third embodiment 80 of a radiopaque marker that is similar to the star-burst marker 70 in that it comprises a core 82 from which extend three fingers 84. Each of the fingers includes radiopaque fibers 86, which are preferably made from Dacron or a similar material.



FIG. 9 illustrates a fourth embodiment 90 of a radiopaque marker having a generally Y-shaped configuration comprising an arm 92 from which extend diverging fingers 94. The arm and fingers 92, 94 are preferably made from a suitable resilient metal such that the fingers can be compressed towards each other and the entire radiopaque marker 90 stored within the marker recess 46 of the cannula. Upon ejection of the marker 90 from the marker recess 46 into the tissue mass, the fingers 94 will spring outwardly to provide the marker 90 with an effectively greater cross-sectional area.


In addition to providing the marker 90 with an effectively greater cross-sectional area, the tips of the fingers 94, together with the free end of the arm 92, effectively form points of contact with the surrounding tissue mass that help to anchor the marker 90 in its release condition to prevent migration through the tissue mass.



FIG. 10 illustrates a fifth embodiment 100 of a radiopaque marker having a wire-form body in a horseshoe-like configuration comprising a rounded bight portion 102 from which extend inwardly tapering legs 104, each of which terminate in curved tips 106. The entire marker 100 preferably has a circular cross section defining a hollow interior 108. The hollow interior provides for the trapping of air within the marker 100 to improve the ultrasound characteristics of the marker 100.


The curved bight portion 102 and legs 104 preferably lie in a common plane. However, the tips 106 extend away from the legs 104 and out of the common plane so that the tips 106 will better function as anchors for the tissue that prolapses about the tips 106 once the marker 100 is ejected from the marker recess 46 and the introducer 12 is withdrawn from the tissue mass.



FIG. 12 illustrates a sixth embodiment 110 of a radiopaque marker that is similar to the horseshoe-like fifth embodiment marker 100 in that it comprises a bight portion 112 from which extend legs 114, which terminate in tips 116. The legs 114 of the marker 110 are crossed relative to each other, unlike the legs of the marker 100, providing the marker 110 with an effectively larger cross-sectional diameter. The tips 116 are oriented at approximately 90° relative to the legs 114 to form anchors. The marker 110 also has a hollow interior 118 for enhanced radiopaque characteristics.


Though, as illustrated in FIG. 12, the tips 116 of the marker 110 are oriented at approximately 90° with respect to the legs 114, it is within the scope of the invention for the tips 116 to extend at substantially any angle with respect to the legs 114. The tips 116 also need not extend away from the legs in the same direction. For example, the tips 116 could extend in opposite directions from the legs 114.



FIG. 13 illustrates a seventh embodiment 120 of a radiopaque marker having a generally helical configuration comprising multiple coils 122 of continuously decreasing radius. The helical marker 120 is preferably made from a radiopaque material and has a hollow interior 124 to enhance its radiopaque characteristics. The decreasing radius of the coils 122 provides the marker 120 with multiple anchor points created by the change in the effective cross-sectional diameter along the axis of the helix. In other words, since the effective cross-sectional diameter of each coil is different from the next and each coil is effectively spaced from adjacent coils at the same diametric location on the helix, the tissue surrounding the marker 120 can prolapse between the spaced coils and each coil effectively provides an anchor point against the tissue to hold the marker 120 in position and prevent its migration through the tissue mass.



FIG. 14 illustrates an eighth embodiment 130 of a radiopaque marker comprising a cylindrical body 132 in which are formed a series of axially spaced circumferential grooves 134. The spaced grooves 134 form a series of ridges 136 therebetween on the outer surface of the cylindrical body 132. The cylindrical body 132 preferably includes a hollow interior 138.


The alternating and spaced ridges 136 and grooves 134 provide the marker 130 with a repeating diameter change along the longitudinal axis of the cylindrical body 132. As with the helical marker 120, the grooves 134 between the ridges 136 provide an area in which the tissue surrounding the marker 130 can prolapse thereby enveloping the ridges 136, which function as anchors for preventing the migration of the marker 130 in the tissue mass.



FIG. 15 illustrates a ninth embodiment 140 of a radiopaque marker comprising a cylindrical body 142 having an axial series of circumferential grooves 144 whose intersections with adjacent grooves form ridges 146. The cylindrical body 142 preferably includes a hollow interior 148. An anchor 150 extends from the cylindrical body 142. The anchor 150 comprises a plate 152 connected to the cylindrical body 142 by a wire 154.


The grooves 144 and ridges 146 of the maker 140 provide anchors in the same manner as the grooves 134 and ridges 136 of the marker 130. The anchor 150 further enhances the non-migrating characteristics of the marker 140 by permitting a large portion of the surrounding tissue mass to prolapse between the plate 150 and the cylindrical body 142.


The fifth through the ninth embodiments all preferably have a wire-form body. The various wire-form body shapes can be formed by stamping the shape from metal stock or the bending of a wire.


It should be noted that virtually all of the embodiments of the radiopaque marker described as being hollow can be made without a hollow interior. Similarly, those without a hollow interior can be made with a hollow interior. The hollow interior improves the ultrasound characteristics of the particular marker beyond the inherent radiopaque and ultrasound characteristics attributable to the marker shape and material. In practice, the use of the hollow interior is limited more by manufacturing and cost considerations rather than by performance.


Also, the shape of each marker can be altered to improve or enhance its non-migrating characteristics by adding an express anchor such as that disclosed in connection with the marker 140 or by modifying the marker to provide more anchor points as may be compatible with the basic configuration of the marker.


The combination of the enhanced radiopaque characteristics of the markers and the enhanced non-migrating features result in markers that are superior in use for identifying biopsy location after completion of the biopsy. The ability to accurately locate the biopsy site greatly reduces the amount of tissue that must be removed in a subsequent surgical procedure if the biopsy is cancerous. Additionally, the marker further enhances the ability to use percutaneous methods for removing the entire lesion, reducing the trauma associated with more radical surgical techniques.


The radiopaque markers described and illustrated herein are smaller than the staple-type clip and embolization coil used heretofore, thereby permitting a cannula of 14 gauge or less.


While the invention has been specifically described in connection with certain specific embodiments thereof, it is to be understood that this is by way of illustration and not of limitation, and the scope of the appended claims should be construed as broadly as the prior art will permit.

Claims
  • 1. A marker for use in the percutaneous marking of a predetermined location in a tissue mass, comprising: a marker body formed by a continuous length of an elongate wire configured to form a pair of legs and a bight portion interposed between the pair of legs, the pair of legs configured to converge from the bight portion without crossing or touching, and each leg of the pair of legs having a free end portion, wherein each free end portion of the pair of legs comprises a tip that projects away from a longitudinal axis of the respective leg to form a respective anchor for fixing the location of the marker in the tissue mass by the tissue mass prolapsing about the respective anchor, and wherein the bight portion and the pair of legs lie in a common plane and at least one tip of the pair of legs projects away from the common plane.
  • 2. The marker according to claim 1, wherein the free end portion of a first leg of the pair of legs has a first arcuate portion that terminates in a first free end and the free end portion of a second leg of the pair of legs has a second arcuate portion that terminates in a second free end, wherein the first free end faces in a direction orthogonal to a direction that the second free end faces.
  • 3. The marker according to claim 1, wherein the tips of the legs project away from the respective legs in different directions.
  • 4. The marker according to claim 1, wherein each of the legs approaches the other leg in a direction from the bight portion toward the free end portion to form an opening between the pair of legs in the common plane having an extent in the common plane that is less than an extent of the bight portion in the common plane.
  • 5. A radiopaque marker for use in the percutaneous marking of a predetermined location in a tissue mass to facilitate subsequent determination of the location of the tissue mass, the radiopaque marker comprising: a marker body formed by a continuous length of an elongate wire configured to form a rounded bight portion from which extend a set of inwardly tapering legs; wherein the set of inwardly tapering legs are configured to converge from the rounded bight portion without crossing or touching each other; wherein each leg of the set of inwardly tapering legs has a free end portion that forms a curved tip; wherein the rounded bight portion and the set of inwardly tapering legs lie in a common plane; and wherein at least one curved tip extends away from a longitudinal axis of the respective leg and projects out of the common plane to form a respective anchor for fixing the location of the marker in the tissue mass by the tissue mass prolapsing about the respective anchor.
  • 6. The radiopaque marker according to claim 5, wherein the free end portion of a first leg of the set of inwardly tapering legs has a first arcuate portion that terminates in a first free end and the free end portion of a second leg of the set of inwardly tapering legs has a second arcuate portion that terminates in a second free end, wherein the first free end faces in a direction orthogonal to a direction that the second free end faces.
  • 7. The radiopaque marker according to claim 5, wherein the free end portion of a first leg of the set of inwardly tapering legs has a first arcuate portion that terminates in a first free end and the free end portion of a second leg of the set of inwardly tapering legs has a second arcuate portion that terminates in a second free end, wherein the first free end faces in a different direction than the direction that the second free end faces.
  • 8. The marker according to claim 5, wherein each of the inwardly tapering legs approaches the other leg in a direction from the bight portion toward the free end portion to form an opening between the set of inwardly tapering legs in the common plane having an extent in the common plane that is less than an extent of the bight portion in the common plane.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a divisional of U.S. patent application Ser. No. 10/421,517 filed Apr. 23, 2003, which is a divisional of U.S. patent application Ser. No. 09/596,610, filed Jun. 16, 2000, which claims the priority of U.S. provisional patent application Ser. No. 60/139,580, filed Jun. 17, 1999. All of the aforementioned application are incorporated herein by reference.

US Referenced Citations (410)
Number Name Date Kind
2907327 White Oct 1959 A
3005457 Millman Oct 1961 A
3128744 Jefferts et al. Apr 1964 A
3402712 Eisenhand Sep 1968 A
3516412 Ackerman Jun 1970 A
3820545 Jefferts Jun 1974 A
3823212 Chvapil Jul 1974 A
3921632 Bardani Nov 1975 A
4005699 Bucalo Feb 1977 A
4007732 Kvavle et al. Feb 1977 A
4041931 Elliott et al. Aug 1977 A
4086914 Moore May 1978 A
4103690 Harris Aug 1978 A
4105030 Kercso Aug 1978 A
4127774 Gillen Nov 1978 A
4197846 Bucalo Apr 1980 A
4217889 Radovan et al. Aug 1980 A
4228799 Anichkov et al. Oct 1980 A
4276885 Tickner et al. Jul 1981 A
4294241 Miyata Oct 1981 A
4347234 Wahlig et al. Aug 1982 A
4390018 Zukowski Jun 1983 A
4400170 McNaughton et al. Aug 1983 A
4401124 Guess et al. Aug 1983 A
4405314 Cope Sep 1983 A
4438253 Casey et al. Mar 1984 A
4442843 Rasor et al. Apr 1984 A
4487209 Mehl Dec 1984 A
4582061 Fry Apr 1986 A
4582640 Smestad et al. Apr 1986 A
4588395 Lemelson May 1986 A
4597753 Turley Jul 1986 A
4647480 Ahmed Mar 1987 A
4655226 Lee Apr 1987 A
4661103 Harman Apr 1987 A
4682606 DeCaprio Jul 1987 A
4693237 Hoffman Sep 1987 A
4813062 Gilpatrick Mar 1989 A
4820267 Harman Apr 1989 A
4832680 Haber et al. May 1989 A
4863470 Carter Sep 1989 A
4874376 Hawkins, Jr. Oct 1989 A
4909250 Smith Mar 1990 A
4950234 Fujioka et al. Aug 1990 A
4963150 Brauman Oct 1990 A
4989608 Ratner Feb 1991 A
4994013 Suthanthiran et al. Feb 1991 A
4994028 Leonard et al. Feb 1991 A
5013090 Matsuura May 1991 A
5018530 Rank et al. May 1991 A
5035891 Runkel et al. Jul 1991 A
5081997 Bosley, Jr. et al. Jan 1992 A
5120802 Mares et al. Jun 1992 A
5125413 Baran Jun 1992 A
5137928 Erbel et al. Aug 1992 A
5141748 Rizzo Aug 1992 A
5147295 Stewart Sep 1992 A
5147307 Gluck Sep 1992 A
5147631 Glajch et al. Sep 1992 A
5162430 Rhee et al. Nov 1992 A
5163896 Suthanthiran et al. Nov 1992 A
5195540 Shiber Mar 1993 A
5197482 Rank et al. Mar 1993 A
5199441 Hogle Apr 1993 A
5201704 Ray Apr 1993 A
5219339 Saito Jun 1993 A
5221269 Miller et al. Jun 1993 A
5234426 Rank et al. Aug 1993 A
5242759 Hall Sep 1993 A
5250026 Ehrlich et al. Oct 1993 A
5273532 Niezink et al. Dec 1993 A
5280788 Janes et al. Jan 1994 A
5281197 Arias et al. Jan 1994 A
5282781 Liprie Feb 1994 A
5284479 de Jong Feb 1994 A
5289831 Bosley Mar 1994 A
5312435 Nash et al. May 1994 A
5320100 Herweck et al. Jun 1994 A
5320613 Houge et al. Jun 1994 A
5328955 Rhee et al. Jul 1994 A
5334216 Vidal et al. Aug 1994 A
5344640 Deutsch et al. Sep 1994 A
5353804 Kornberg et al. Oct 1994 A
5354623 Hall Oct 1994 A
5358514 Schulman et al. Oct 1994 A
5368030 Zinreich et al. Nov 1994 A
5388588 Nabai et al. Feb 1995 A
5394875 Lewis et al. Mar 1995 A
5395319 Hirsch et al. Mar 1995 A
5405402 Dye et al. Apr 1995 A
5409004 Sloan Apr 1995 A
5417708 Hall et al. May 1995 A
5431639 Shaw Jul 1995 A
5449560 Antheunis et al. Sep 1995 A
5458643 Oka et al. Oct 1995 A
5460182 Goodman et al. Oct 1995 A
5469847 Zinreich et al. Nov 1995 A
5475052 Rhee et al. Dec 1995 A
5490521 Davis et al. Feb 1996 A
5499989 LaBash Mar 1996 A
5507807 Shippert Apr 1996 A
5508021 Grinstaff et al. Apr 1996 A
5514085 Yoon May 1996 A
5522896 Prescott Jun 1996 A
5542915 Edwards et al. Aug 1996 A
5545180 Le et al. Aug 1996 A
5549560 Van de Wijdeven Aug 1996 A
5567413 Klaveness et al. Oct 1996 A
RE35391 Brauman Dec 1996 E
5585112 Unger et al. Dec 1996 A
5611352 Kobren et al. Mar 1997 A
5626611 Liu et al. May 1997 A
5628781 Williams et al. May 1997 A
5629008 Lee May 1997 A
5657366 Nakayama Aug 1997 A
5665092 Mangiardi et al. Sep 1997 A
5669882 Pyles Sep 1997 A
5673841 Schulze et al. Oct 1997 A
5676146 Scarborough Oct 1997 A
5690120 Jacobsen et al. Nov 1997 A
5702128 Maxim et al. Dec 1997 A
5702682 Thompson Dec 1997 A
5702716 Dunn et al. Dec 1997 A
5716981 Hunter et al. Feb 1998 A
5752974 Rhee et al. May 1998 A
5769086 Ritchart et al. Jun 1998 A
5779647 Chau et al. Jul 1998 A
5782764 Werne Jul 1998 A
5782771 Hussman Jul 1998 A
5782775 Milliman et al. Jul 1998 A
5795308 Russin Aug 1998 A
5799099 Wang et al. Aug 1998 A
5800362 Kobren et al. Sep 1998 A
5800389 Burney et al. Sep 1998 A
5800445 Ratcliff et al. Sep 1998 A
5800541 Rhee et al. Sep 1998 A
5821184 Haines et al. Oct 1998 A
5823198 Jones et al. Oct 1998 A
5824042 Lombardi et al. Oct 1998 A
5824081 Knapp et al. Oct 1998 A
5826776 Schulze et al. Oct 1998 A
5842999 Pruitt et al. Oct 1998 A
5830178 Jones et al. Nov 1998 A
5830222 Makower Nov 1998 A
5842477 Naughton et al. Dec 1998 A
5845646 Lemelson Dec 1998 A
5853366 Dowlatshahi Dec 1998 A
5865806 Howell Feb 1999 A
5871501 Leschinsky et al. Feb 1999 A
5876340 Tu et al. Mar 1999 A
5879357 Heaton Mar 1999 A
5891558 Bell et al. Apr 1999 A
5897507 Kortenbach et al. Apr 1999 A
5902310 Foerster et al. May 1999 A
5911705 Howell Jun 1999 A
5916164 Fitzpatrick et al. Jun 1999 A
5921933 Sarkis et al. Jul 1999 A
5928773 Andersen Jul 1999 A
5941439 Kammerer et al. Aug 1999 A
5941890 Voegele et al. Aug 1999 A
5948425 Janzen et al. Sep 1999 A
5954670 Baker Sep 1999 A
5972817 Haines et al. Oct 1999 A
5976146 Ogawa et al. Nov 1999 A
5980564 Stinson Nov 1999 A
5989265 Bouquet De La Joliniere et al. Nov 1999 A
6030333 Sioshansi et al. Feb 2000 A
6053925 Barnhart Apr 2000 A
6056700 Burney et al. May 2000 A
6066122 Fisher May 2000 A
6071301 Cragg et al. Jun 2000 A
6071310 Picha et al. Jun 2000 A
6090996 Li Jul 2000 A
6069070 Ragheb et al. Aug 2000 A
6096065 Crowley Aug 2000 A
6106473 Violante et al. Aug 2000 A
6117108 Woehr et al. Sep 2000 A
6120536 Ding et al. Sep 2000 A
6135993 Hussman Oct 2000 A
6142955 Farascioni et al. Nov 2000 A
6159240 Sparer et al. Dec 2000 A
6161034 Burbank et al. Dec 2000 A
6162192 Cragg et al. Dec 2000 A
6166079 Follen et al. Dec 2000 A
6173715 Sinanan et al. Jan 2001 B1
6174330 Stinson Jan 2001 B1
6181960 Jensen et al. Jan 2001 B1
6183497 Sing et al. Feb 2001 B1
6190350 Davis et al. Feb 2001 B1
6190353 Makower et al. Feb 2001 B1
6200258 Slater et al. Mar 2001 B1
6203507 Wadsworth et al. Mar 2001 B1
6203524 Burney et al. Mar 2001 B1
6203568 Lombardi et al. Mar 2001 B1
6213957 Milliman et al. Apr 2001 B1
6214045 Corbitt, Jr. et al. Apr 2001 B1
6220248 Voegele et al. Apr 2001 B1
6224630 Bao et al. May 2001 B1
6228049 Schroeder et al. May 2001 B1
6228055 Foerster et al. May 2001 B1
6231615 Preissman May 2001 B1
6234177 Barsch May 2001 B1
6241687 Voegele et al. Jun 2001 B1
6241734 Scribner et al. Jun 2001 B1
6251135 Stinson et al. Jun 2001 B1
6251418 Ahern et al. Jun 2001 B1
6261243 Burney et al. Jul 2001 B1
6261302 Voegele et al. Jul 2001 B1
6270454 Fulton, III et al. Aug 2001 B1
6270464 Fulton, III et al. Aug 2001 B1
6270472 Antaki et al. Aug 2001 B1
6287278 Woehr et al. Sep 2001 B1
6287332 Bolz et al. Sep 2001 B1
6289229 Crowley Sep 2001 B1
6306154 Hudson et al. Oct 2001 B1
6312429 Burbank et al. Nov 2001 B1
6325789 Janzen et al. Dec 2001 B1
6335029 Kamath et al. Jan 2002 B1
6336904 Nikolchev Jan 2002 B1
6340367 Stinson et al. Jan 2002 B1
6343227 Crowley Jan 2002 B1
6350244 Fisher et al. Feb 2002 B1
6354989 Nudeshima Mar 2002 B1
6356782 Sirimanne et al. Mar 2002 B1
6358217 Bourassa Mar 2002 B1
6371904 Sirimanne et al. Apr 2002 B1
6405733 Fogarty et al. Jun 2002 B1
6409742 Fulton, III et al. Jun 2002 B1
6419621 Sioshansi et al. Jul 2002 B1
6425903 Voegele Jul 2002 B1
6427081 Burbank et al. Jul 2002 B1
6436030 Rehil Aug 2002 B2
6447524 Knodel et al. Sep 2002 B1
6447527 Thompson et al. Sep 2002 B1
6450938 Miller Sep 2002 B1
6471700 Burbank et al. Oct 2002 B1
6506156 Jones et al. Jan 2003 B1
6511468 Cragg et al. Jan 2003 B1
6511650 Eiselt et al. Jan 2003 B1
6537193 Lennox Mar 2003 B1
6551253 Worm et al. Apr 2003 B2
6564806 Fogarty et al. May 2003 B1
6565551 Jones et al. May 2003 B1
6567689 Burbank et al. May 2003 B2
6575991 Chesbrough et al. Jun 2003 B1
6585773 Xie Jul 2003 B1
6605047 Zarins et al. Aug 2003 B2
6610026 Cragg et al. Aug 2003 B2
6613002 Clark et al. Sep 2003 B1
6616630 Woehr et al. Sep 2003 B1
6626850 Chau et al. Sep 2003 B1
6629947 Sahatjian et al. Oct 2003 B1
6636758 Sanchez et al. Oct 2003 B2
6638234 Burbank et al. Oct 2003 B2
6656192 Espositio et al. Dec 2003 B2
6662041 Burbank et al. Dec 2003 B2
6699205 Fulton, III et al. Mar 2004 B2
6712774 Voegele et al. Mar 2004 B2
6712836 Berg et al. Mar 2004 B1
6716444 Castro et al. Apr 2004 B1
6725083 Burbank et al. Apr 2004 B1
6730042 Fulton et al. May 2004 B2
6730044 Stephens et al. May 2004 B2
6746773 Llanos et al. Jun 2004 B2
6752154 Fogarty et al. Jun 2004 B2
6766186 Hoyns et al. Jul 2004 B1
6774278 Ragheb et al. Aug 2004 B1
6824527 Gollobin Nov 2004 B2
6846320 Ashby et al. Jan 2005 B2
6862470 Burbank et al. Mar 2005 B2
6863685 Davila et al. Mar 2005 B2
6881226 Corbitt, Jr. et al. Apr 2005 B2
6899731 Li et al. May 2005 B2
6918927 Bates et al. Jul 2005 B2
6951564 Espositio et al. Oct 2005 B2
6958044 Burbank et al. Oct 2005 B2
6993375 Burbank et al. Jan 2006 B2
6994712 Fisher et al. Feb 2006 B1
6996433 Burbank et al. Feb 2006 B2
7001341 Gellman et al. Feb 2006 B2
7008382 Adams et al. Mar 2006 B2
7014610 Koulik Mar 2006 B2
7025765 Balbierz et al. Apr 2006 B2
7044957 Foerster et al. May 2006 B2
7047063 Burbank et al. May 2006 B2
7083576 Zarins et al. Aug 2006 B2
7125397 Woehr et al. Oct 2006 B2
7214211 Woehr et al. May 2007 B2
7229417 Foerster et al. Jun 2007 B2
7236816 Kumar et al. Jun 2007 B2
7264613 Woehr et al. Sep 2007 B2
7294118 Saulenas et al. Nov 2007 B2
7297725 Winterton et al. Nov 2007 B2
7329402 Unger et al. Feb 2008 B2
7416533 Gellman et al. Aug 2008 B2
7424320 Chesbrough et al. Sep 2008 B2
7449000 Adams et al. Nov 2008 B2
7527610 Erickson May 2009 B2
7565191 Burbank et al. Jul 2009 B2
7569065 Chesbrough et al. Aug 2009 B2
7577473 Davis et al. Aug 2009 B2
7637948 Corbitt, Jr. Dec 2009 B2
7668582 Sirimanne et al. Feb 2010 B2
7792569 Burbank et al. Sep 2010 B2
7844319 Susil et al. Nov 2010 B2
7871438 Corbitt, Jr. Jan 2011 B2
8052708 Chesbrough et al. Nov 2011 B2
8157862 Corbitt, Jr. Apr 2012 B2
8306602 Sirimanne et al. Nov 2012 B2
8320993 Sirimanne et al. Nov 2012 B2
8320994 Sirimanne et al. Nov 2012 B2
8361082 Jones et al. Jan 2013 B2
8579931 Chesbrough et al. Nov 2013 B2
8626270 Burbank et al. Jan 2014 B2
8668737 Corbitt, Jr. Mar 2014 B2
20010014778 Worm et al. Aug 2001 A1
20020004060 Heublein et al. Jan 2002 A1
20020016625 Falotico et al. Feb 2002 A1
20020026201 Foerster et al. Feb 2002 A1
20020035324 Sirimanne et al. Mar 2002 A1
20020045842 Van Bladel et al. Apr 2002 A1
20020058868 Hoshino et al. May 2002 A1
20020077687 Ahn Jun 2002 A1
20020082519 Miller et al. Jun 2002 A1
20020082682 Barclay et al. Jun 2002 A1
20020095204 Thompson et al. Jul 2002 A1
20020098278 Bates et al. Jul 2002 A1
20020107437 Sirimanne et al. Aug 2002 A1
20020143359 Fulton, III et al. Oct 2002 A1
20020165608 Llanos et al. Nov 2002 A1
20020177776 Crawford Kellar et al. Nov 2002 A1
20020188196 Burbank et al. Dec 2002 A1
20020193815 Foerester et al. Dec 2002 A1
20020193867 Gladdish, Jr. et al. Dec 2002 A1
20030225420 Wardle Dec 2003 A1
20030233101 Lubock et al. Dec 2003 A1
20040016195 Archuleta Jan 2004 A1
20040024304 Foerster et al. Feb 2004 A1
20040044311 Espositio et al. Mar 2004 A1
20040068312 Sigg et al. Apr 2004 A1
20040073107 Sioshansi et al. Apr 2004 A1
20040073284 Bates et al. Apr 2004 A1
20040097981 Sells May 2004 A1
20040101479 Burbank et al. May 2004 A1
20040106891 Langan et al. Jun 2004 A1
20040116802 Jessop et al. Jun 2004 A1
20040124105 Seiler et al. Jul 2004 A1
20040127765 Seiler et al. Jul 2004 A1
20040162574 Viola Aug 2004 A1
20040210208 Paul et al. Oct 2004 A1
20040236212 Jones et al. Nov 2004 A1
20050019262 Chernomorsky et al. Jan 2005 A1
20050020916 MacFarlane et al. Jan 2005 A1
20050033157 Klein et al. Feb 2005 A1
20050033195 Fulton et al. Feb 2005 A1
20050036946 Pathak et al. Feb 2005 A1
20050038355 Gellman et al. Feb 2005 A1
20050049489 Foerster et al. Mar 2005 A1
20050059888 Sirimanne et al. Mar 2005 A1
20050063908 Burbank et al. Mar 2005 A1
20050080337 Sirimanne et al. Apr 2005 A1
20050080339 Sirimanne et al. Apr 2005 A1
20050100580 Osborne et al. May 2005 A1
20050113659 Pothier et al. May 2005 A1
20050119562 Jones et al. Jun 2005 A1
20050143650 Winkel Jun 2005 A1
20050165305 Foerster et al. Jul 2005 A1
20050234336 Beckman et al. Oct 2005 A1
20050273002 Goosen et al. Dec 2005 A1
20050277871 Sells Dec 2005 A1
20060036158 Field et al. Feb 2006 A1
20060036159 Sirimanne et al. Feb 2006 A1
20060036165 Burbank et al. Feb 2006 A1
20060074443 Foerster et al. Apr 2006 A1
20060079805 Miller et al. Apr 2006 A1
20060079829 Fulton et al. Apr 2006 A1
20060116573 Field et al. Jun 2006 A1
20060122503 Burbank et al. Jun 2006 A1
20060173280 Goosen et al. Aug 2006 A1
20060173296 Miller et al. Aug 2006 A1
20060177379 Asgari Aug 2006 A1
20060217635 McCombs et al. Sep 2006 A1
20060235298 Kotmel et al. Oct 2006 A1
20060241411 Field et al. Oct 2006 A1
20070038145 Field Feb 2007 A1
20070083132 Sharrow Apr 2007 A1
20070087026 Field Apr 2007 A1
20070135711 Chernomorsky et al. Jun 2007 A1
20070142725 Hardin et al. Jun 2007 A1
20070239118 Ono et al. Oct 2007 A1
20070287933 Phan et al. Dec 2007 A1
20080033280 Lubock et al. Feb 2008 A1
20080097199 Mullen Apr 2008 A1
20080188768 Zarins et al. Aug 2008 A1
20080269638 Cooke et al. Oct 2008 A1
20090030309 Jones et al. Jan 2009 A1
20090069713 Adams et al. Mar 2009 A1
20090093714 Chesbrough et al. Apr 2009 A1
20090131825 Burbank et al. May 2009 A1
20100010342 Burbank et al. Jan 2010 A1
20100198059 Burbank et al. Aug 2010 A1
20100324416 Burbank et al. Dec 2010 A1
20110184280 Jones et al. Jul 2011 A1
20120078092 Jones et al. Mar 2012 A1
20120116215 Jones et al. May 2012 A1
20130144157 Jones et al. Jun 2013 A1
20130281847 Jones et al. Oct 2013 A1
20140058258 Chesbrough et al. Feb 2014 A1
20140094698 Burbank et al. Apr 2014 A1
20140142696 Corbitt, Jr. May 2014 A1
Foreign Referenced Citations (25)
Number Date Country
1 029 528 May 1958 DE
0255123 Feb 1988 EP
0292936 Nov 1988 EP
0458745 Nov 1991 EP
0475077 Mar 1992 EP
0552924 Jul 1993 EP
0 769 280 Apr 1997 EP
0 769 281 Apr 1997 EP
1163888 Dec 2001 EP
1364628 Nov 2003 EP
0146699 Oct 2008 EP
2646674 Nov 1990 FR
2853521 Oct 2004 FR
WO 9608208 Mar 1996 WO
9806346 Feb 1998 WO
9908607 Feb 1999 WO
9951143 Oct 1999 WO
0023124 Apr 2000 WO
0024332 May 2000 WO
WO 0028554 May 2000 WO
0108578 Feb 2001 WO
0170114 Sep 2001 WO
03000308 Jan 2003 WO
2004045444 Jun 2004 WO
2006097331 Sep 2006 WO
Non-Patent Literature Citations (13)
Entry
Johnson & Johnson: Breast Biopsy (minimally invasive): Surgical Technique: Steps in the Mamotome Surgical Procedure. From http://www.jnjgateway.com. 3 pages.
Johnson & Johnson: New Minimally Invasive Breast Biopsy Device Receives Marketing Clearance in Canada; Aug. 6, 1999. From http://www.jnjgateway.com. 4 pages.
Johnson & Johnson: Mammotome Hand Held Receives FDA Marketing Clearance for Minimally Invasive Breast Biopises; Sep. 1, 1999. From From http://www.jnjgateway.com. 5 pages.
Cook Incorporated: Emoblization and Occlusion. From: www.cookgroup.com 6 pages.
Crook, et al. (Prostate Motion During Standard Radiotherapy as Assessed by Fiducial Markers, 1995, Radiotherapy and Oncology 37:35-42.).
Fajardo, Laurie, et al., “Placement of Endovascular Embolization Microcoils to Localize the Site of Breast Lesions Removed at Stereotactic Core Biopsy”, Radiology, Jan. 1998, pp. 275-278, vol. 206—No. 1.
Press release for Biopsys Ethicon Endo-Surgery (Europe) GmbH; The Mammotome Vacuum Biopsy System. From: http://www.medicine-news.com/articles/devices/mammotome.html. 3 pages.
Johnson & Johnson: Breast Biopsy (minimally invasive): Surgical Technique: Steps in the Mammotome Surgical Procedure. From http://www.jnjgateway.com. 3 pages.
Johnson & Johnson: New Minimally Invasive Breast Biopsy Device Receives Marketing Clearance in Canada; Aug. 6, 1999. From: http://www.jnj.com. 4 pages.
Johnson & Johnson: Mammotome Hand Held Receives FDA Marketing Clearance for Minimally Invasive Breast Biopsies; Sep. 1, 1999. From: http://www.jnj.com. 5 pages.
Johnson & Johnson: The Mammotome Breast Biopsy System. From: http://www.breastcareinfo.com/aboutm.htm. 6 pages.
Cook Incorporated: Embolization and Occlusion. From: www.cookgroup.com. 6 pages.
Liberman, Laura, et al. Percutaneous Removal of Malignant Mammographic Lesions at Stereotactic Vacuum-assisted Biopsy. From: The Departments of Radiology, Pathology, and Surgery. Memorial Sloan-Kettering Cancer Center. From the 1997 RSNA scientific assembly. vol. 206, No. 3. pp. 711-715.
Related Publications (1)
Number Date Country
20060025795 A1 Feb 2006 US
Provisional Applications (1)
Number Date Country
60139580 Jun 1999 US
Divisions (2)
Number Date Country
Parent 10421517 Apr 2003 US
Child 11162814 US
Parent 09596160 Jun 2000 US
Child 10421517 US